CNBC’s Meg Tirrell joins ‘Squawk Box’ to report that Biogen CEO Michel Vounatsos will step down amid the company’s troubled launch of its historic Alzheimer’s drug Aduhelm.
Biogen CEO Michel Vounatsos to step down following troubled Alzheimer’s drug launch
Tweet on Twitter
Share on Facebook
Pinterest
